View Older Stories View More Recent Stories

Nov 14, 2024 04:16PM Halozyme Therapeutics (HALO) Confirms Proposal to Combine with Evotec (EVO) for €11.00 Per Share in an All-Cash Transaction
Nov 14, 2024 04:15PM Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
May 14, 2024 08:30AM CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
Apr 18, 2024 07:27AM Evotec (EVO) And Variant Bio Enter Strategic Partnership To Discover And Develop Fibrosis Treatments
Apr 18, 2024 07:27AM EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS
Nov 7, 2023 01:30AM Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
Nov 2, 2023 08:30AM EVT and IMAX® Expand Partnership with Five New IMAX Locations in Australia and Germany
Apr 11, 2023 08:30AM RenovoRx Appoints Leesa Gentry as Senior Vice President of Clinical Operations
Dec 6, 2022 07:00AM Exscientia Presents Novel Immuno-Oncology Biomarker for EXS-21546 at the ESMO I-O Annual Congress
Nov 28, 2022 07:01AM Exscientia plc (EXAI) Receives First CTA Approval to Initiate IGNITE-AI, a Phase 1/2 Trial of EXS-21546 in Patients with Advanced Solid Tumours
Nov 28, 2022 07:00AM Exscientia Receives First CTA Approval to Initiate IGNITE-AI, a Phase 1/2 Trial of EXS-21546 in Patients with Advanced Solid Tumours
Oct 17, 2022 07:00AM TIAP and Evotec Expand LAB150 BRIDGE Partnership to Include Amgen
Sep 21, 2022 06:00AM Adapsyn Bioscience enters into strategic collaboration with Evotec
Aug 10, 2022 01:30AM Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303
Jun 14, 2022 08:04AM Exscientia plc (EXAI) Reports Topline Data From EXS-21546 Phase 1a Study Demonstrating Targeted A2A Receptor Signaling Inhibition in Healthy Volunteers
Jun 14, 2022 08:00AM Exscientia Reports Topline Data From EXS-21546 Phase 1a Study Demonstrating Targeted A2A Receptor Signaling Inhibition in Healthy Volunteers
Nov 18, 2021 07:00AM EQRx and Evotec Announce Integrated Drug Discovery and Development Partnership
Aug 20, 2020 01:30AM CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease
Jun 24, 2020 07:00AM Samsara BioCapital, Evotec and KCK Launch Autobahn Labs, a Novel Early Stage Drug Discovery Incubator
Jan 23, 2020 03:00AM Evotec and Indivumed Announce Second Joint Drug Discovery Program
Sep 30, 2019 08:00AM Evotec And Indivumed Achieve Milestone In Joint Strategic Drug Discovery Collaboration
Oct 17, 2018 01:00AM Ferring and Evotec Form Strategic Research Alliance in Reproductive Medicine and Women’s Health
Aug 27, 2018 01:30AM CENTOGENE and Evotec Sign Global Strategic Partnership on Drug Discovery Projects in Rare Genetic Diseases
May 31, 2018 01:56AM Evotec Forms Academic Bridge 'LAB591' with Arix Bioscience and Fred Hutchinson Cancer Research Center
May 29, 2018 12:36PM Evotec and Celgene (CELG) Expand IPSC Collaboration to Include Additional Cell Lines
May 29, 2018 12:35PM Evotec and Celgene Expand IPSC Collaboration to Include Additional Cell Lines
May 22, 2018 06:24AM Evotec and Celgene (CELG) Enter into Strategic Oncology Partnership
May 22, 2018 01:25AM Evotec and Celgene Enter into Strategic Oncology Partnership
May 9, 2018 01:32AM Evotec Reports First Quarter 2018 Results and Provides Corporate Update
May 8, 2018 01:54AM Evotec and Carna Biosciences Collaborate on Indigo Platform
May 4, 2018 08:38AM Evotec to Present at Upcoming Investor Conferences
May 2, 2018 09:25AM Evotec AG to Report First Quarter 2018 Results on 09 May 2018
May 2, 2018 02:26AM Evotec Expands CRISPR-Based Technology Offering with Licence from ERS Genomics
Apr 18, 2018 02:28AM Evotec and Bayer Advance Third Endometriosis Programme into Phase I Clinical Development
Apr 11, 2018 02:12AM Evotec Forms Collaboration with Petra Pharma on Indigo Platform
Mar 28, 2018 01:38AM Evotec AG Fiscal Year 2017 Results: Leading External Innovation
Mar 26, 2018 02:01AM Evotec Launches INDIGO, A Unique Integrated Drug Development Solution for Accelerating Early Drug Candidates into the Clinic
Mar 21, 2018 09:28AM Evotec AG to Report Fiscal Year 2017 Results on 28 March 2018
Mar 8, 2018 02:44AM Evotec and Sanofi in Exclusive Talks to Create an Evotec-Led Infectious Disease Open Innovation R&D Platform
Mar 7, 2018 09:56AM Evotec to Attend Upcoming Investor Conferences
Feb 15, 2018 02:51AM Evotec and MaRS Innovation Announce First Funded Project under LAB150 Bridge
Jan 8, 2018 03:02AM APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
Jan 8, 2018 02:15AM Evotec and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sanofi
Jan 3, 2018 06:26AM Evotec to Attend Upcoming Investor Conferences
Dec 13, 2017 02:14AM Evotec Enters into Research Collaboration with CRTD to Discover Novel Therapies for Retinal Diseases
Dec 11, 2017 02:31AM Evotec's Academic Bridge LAB282 with Oxford University Celebrating One Year of Impact
Dec 4, 2017 08:00AM Ncardia and Evotec Entered a Licencing Agreement for Disease Modelling Using iPS Cells
Dec 1, 2017 02:28AM EVOTEC RECEIVES CLINICAL MILESTONE AS PART OF ITS DISCOVERY ALLIANCE WITH BOEHRINGER INGELHEIM
Nov 9, 2017 10:37AM Evotec to Attend Upcoming Investor Conferences
Nov 8, 2017 03:12AM Evotec AG Announces First Nine-Month 2017 Results and Corporate Update
View More Recent Stories View Older Stories